Texts for Diabetes Control Among Homeless Persons

Last updated: December 19, 2024
Sponsor: George Washington University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Prevention

Diabetes And Hypertension

Treatment

Attention Control

Intervention

Clinical Study ID

NCT05616026
#11-21-ICTSHD-16
  • Ages > 21
  • All Genders

Study Summary

This mixed method study includes a Randomized Controlled Trial (RCT) and qualitative methods to assess the impact of a SMS text strategy in diabetes control among persons who experience homelessness.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Homeless person age ≥ 21

  • Diagnosed with type 2 DM

  • Most recent visit HbA1c ≥ 8%

  • English/Spanish speaking

  • Connected to study sites' shelter-clinics for care

Exclusion

Exclusion Criteria:

  • Pregnant or within 3 months postpartum

  • Has an uncontrolled severe illness

  • Has had a heart attack or stroke in the previous 6 months

  • Inability to read/respond to texts

  • Inability to provide informed consent

  • Receiving inpatient care for severe substance abuse

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Attention Control
Phase:
Study Start date:
February 07, 2023
Estimated Completion Date:
November 15, 2025

Study Description

Diabetes mellitus (DM) is common among persons experiencing homelessness (PEH), often inadequately managed, and carries significant costs. SMS strategies for DM have not been tested among PEH despite the accessibility of mobile phones. This study uses a SMS strategy to offer better communication, education, and information management; improve outreach; facilitate care coordination; explore barriers to care; and support behavior changes. This mixed-methods (RCT and qualitative) study will be implemented in shelter-clinics in New York City in collaboration with community organizations, allowing for sustainability and scalability. Aim 1 will evaluate the efficacy of a 6-month SMS program for DM management versus an attention control on changes in HbA1c and adherence to DM self-care activities, medications, and appointments at 9 months in adult PEH with uncontrolled DM (n=100). Outcomes will be measured at 0, 3, 6, &9 months. Aim 2 will assess patients' and providers' attitudes, acceptability, and experience of the program through semi-structured interviews with PEH and providers.

Connect with a study center

  • George Washington University

    Washington, District of Columbia 20052
    United States

    Active - Recruiting

  • NYU Langone Health

    New York, New York 10003
    United States

    Site Not Available

  • NYU Langone Health

    New York City, New York 10003
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.